Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements
Helen Phillips-Jackson,1 Clive Hallam,2 Niamh Cullen,3 Terry Pearson,4 Mark Gilman,5 Li Li,6 Paul Musgrave7 1Working Group on Innovation Assessment, Expert Faculty on Commissioning, London, UK; 2Richmond and Wandsworth Council, London, UK; 3Public Health, Calderdale, UK; 4Northamptonshire County Cou...
Main Authors: | Phillips-Jackson H, Hallam C, Cullen N, Pearson T, Gilman M, Li L, Musgrave P |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-05-01
|
Series: | ClinicoEconomics and Outcomes Research |
Subjects: | |
Online Access: | https://www.dovepress.com/budget-impact-analysis-of-the-introduction-of-injectable-prolonged-rel-peer-reviewed-article-CEOR |
Similar Items
-
Prolonged-release opioid agonist therapy: qualitative study exploring patients’ views of 1-week, 1-month, and 6-month buprenorphine formulations
by: Joanne Neale, et al.
Published: (2019-04-01) -
OUD Care Service Improvement with Prolonged-release Buprenorphine in Prisons: Cost Estimation Analysis
by: Wright N, et al.
Published: (2020-09-01) -
Budget Impact Analysis of prolonged-release buprenorphine depot-formulation for the management of patients affected by opioid use disorder
by: Michele Basile, et al.
Published: (2021-07-01) -
Extended-release buprenorphine induction in opioid non-tolerant incarcerated individuals
by: Michael S. Gordon, et al.
Published: (2024-09-01) -
Transition From Full Mu Opioid Agonists to Buprenorphine in Opioid Dependent Patients—A Critical Review
by: Michael Soyka
Published: (2021-11-01)